Nuvo Pharmaceuticals Inc NRIFF

RE:RE:Anyone have market depth they can post on nri?

[alpi1441]

The previous management enriched themselves to the detriment of shareholders for years, they  wasted opportunities to increase the market for P1 and really blew P2. By not focusing on the known indication for P2 distribution they did a ankle sprain study not one but two times.
Had they first done an osteoporosis of the knee they could have had P2 in Canada, Greece and Italy. These countries would not have been huge in the way of sales but would have helped, Greece was once a big market for NRI but their financial troubles curtailed the market. I was in Greece three years ago my uncle was using Pennsaid for his knee pain.
This management so far anyhow has not shown they will right the wrongs of the past. Glad I sold awhile ago,  still disappointed though it had potential and I still use P1 on my elbows when arthritis bothers me.